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ABSTRACT 
 
 
Mechanism of hypoxia-induced hypersecretion in paranasal sinusitis 
 
Yoon-Ju Kim 
 
Department of Medical Science  
The Graduate School, Yonsei University 
 
 
(Directed by Professor Joo-Heon Yoon) 
 
 
 
 Excessive mucus production and hypersecretion characterize various upper 
airway diseases. In sinusitis, the expression of major respiratory mucin genes, such 
as MUC5AC, MUC5B is increased. However, the primary mechanisms leading to 
mucus hypersecretion in sinusitis are not well known. Hypoxia due to occlusion of 
sinus ostium is known to be one of the major pathologic mechanisms of the sinusitis. 
However, there has been no report about the mechanism of hypoxia-induced 
hypersecretion of mucus in sinusitis. This study is aimed to identify whether 
induces mucus hypersecretion in upper airway epithelia and to elucidate the 
mechanism of hypoxia-induced hypersecretion in upper airway epithelia. 
 Here we show that expression of mRNA of MUC5AC is a function of time 
under hypoxia in normal human nasal epithelial cells. Our results also show that the 
expression of MUC5AC mRNA was increased by transfection of mammalian 
expression vector encoding HIF-1α, a major transcription factor for hypoxia, even 
under normoxic condition in human lung mucoepidermoid carcinoma cell lines 
(NCI-H292 cells). Moreover, the induced expression of MUC5AC mRNA by 
 2 
hypoxia was down-regulated by transfection of siRNA for HIF-1α. The luciferase 
assay for MUC5AC promoter demonstrated increased reporter activity under 
hypoxic condition, however the mutation of the putative HRE in MUC5AC 
promoter attenuated the reporter activity. We also confirmed the binding of over-
expressed HIF-1α and hypoxia-response element (HRE) in the promoter of 
MUC5AC by electromobility shift assay. In human sinusitis mucosa, we found the 
overexpression of HIF-1α and MUC5AC compared to normal sinus mucosa. 
 Hypoxia upregulates MUC5AC expression by binding of HIF-1α to HRE 
in the promoter of MUC5AC. In conclusion, hypoxia upregulates mucin gene 
expression and secretion by signaling using HIF-1α in the airway epithelia and 
hypoxia might be a pathophysiologic mechanism of hypersecretion in airway 
disease such as sinusitis. 
 
 
 
 
 
 
 
 
 
 
 
 
----------------------------------------------------------------------------------------------------- 
Key words : hypoxia, hypoxia-inducible factor, hypoxia-response element, 
MUC5AC, airway epithelium 
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I. INTRODUCTION 
 
 The epithelial surface of mammalian respiratory, gastrointestinal and 
reproductive tracts is coated by mucus, which is a mixture of water, glycoproteins, 
proteins and lipids. Mucus provides a protective barrier to epithelial compartment 
against pathogens and toxins. Mucus belongs to innate defensive system in mucosal 
immune function. Mucins are the major molecular constituents of mucus and have 
been implicated in health and disease. Mucin family is composed of secretory 
mucins and membrane-tethered mucins that integrated into the cell membrane.
1
 
Twenty human mucin genes are deposited in GenBank. Among them, MUC5AC 
and MUC5B are two major airway mucins.
2
 In airway tissues from healthy 
individuals, goblet cells typically express and secret MUC5AC mRNA and protein, 
while glandular mucosal cells express and secrete MUC5B mRNA and protein.
3
 
 Mucus hypersecretion is known to be a major factor in the pathogenesis of 
the sinus disease such as paranasal sinusitis. Other reports found that levels of 
 4 
MUC5AC and MUC5B mRNA in chronic rhinosinusitis were significantly 
increased compared with those in normal sinus mucosa. It has been reported that 
many infectious mediators and inflammatory/immune response mediators activate 
the transcription of the mucin genes.
4
 
 In the pathophysiologic mechanism of sinusitis, hypoxia in the sinus 
cavities is considered as a major pathogenic factor that causes initiation and 
progression of the disease.
5
 This hypoxia reflects occlusion of the sinus ostium 
which results in failure of transepithelial oxygenation, nonvascularized exudates, 
and the tendency of inflammatory hyperplasia to exceed neovascularization.
6
 The 
severity of sinus mucosal disease which correlates with opacity on computed 
tomography scan is reported to be related to the level of oxygen in the sinuses of 
patients with acute sinusitis.
7
 In chronic sinusitis, the tissue hyperplasia and polyp 
growth can overwhelm neovascularization, further impacting local tissue hypoxia.
8
 
When the bulk of tissue and secretion becomes great enough, the sinuses become 
occluded and oxygenation of the sinus cavity is decreased. 
 It is believed that hypoxia-inducible factor-1 (HIF-1), a basic helix-loop-
helix transcription factor of the PAS family
9
 plays an essential role in the cellular 
response to hypoxic stress by transcriptional activation of various hypoxia-
inducible genes, such as those encoding erythropoietin,
10,11
 vascular endothelial 
growth factor,
12
 glycolytic enzymes,
13
 glucouse transporters,
13
 inducible nitric-
oxide synthase,
14
 heme oxygenase-1,
15
 and transferrin,
16
 in order to maintain 
oxygen homeostasis. HIF-1 is a heterodimer which is composed of an alpha and a 
beta subunit,
17
 the latter being a constitutively-expressed aryl hydrocarbon receptor 
(ARNT).
18
 The activity of the HIF-1 is primarily determined by hypoxia-induced 
stabilization of HIF-1α which becomes rapidly degraded through the ubiquitin-
proteasome pathway.
19
 In hypoxia, stabilized HIF-1α dimerizes with HIF-1β and 
binds to the hypoxia-response element (HRE) in order to recruit the transcription 
coactivator p300/CBP onto the promoter of hypoxia-responsive genes for 
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transcriptional activation. HRE is usually located at the proximal promoter (~100 
bp) which contains one or more of the HIF-1 binding sites (consensus sequence 5’-
[A/G]CGTG-3’).
20
 Mutation of HRE results in the loss of transcriptional response 
to hypoxia.
21
 The presence of an HIF-1 binding site is necessary but not sufficient 
for hypoxia-response-element function.
21,22
 
 We noticed that the promoter region of the MUC5AC gene contains a 
sequence very similar to the consensus HRE within a 70 bp sequence upstream of 
the transcriptional start site. Therefore, in this study, we aimed to identify if 
hypoxia induced mucus hypersecretion and to elucidate the mechanism of hypoxia-
induced hypersecretion in upper airway epithelia.
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II. MATERIALS AND METHODS 
 
1. Cell culture and hypoxia treatment 
 Passage-2 normal human nasal epithelial (NHNE) cells were prepared as 
described previously.
23
 Passage-2 NHNE cells (1 x 10
5 
cells) were seeded in 0.5 ml 
of culture medium on 24.5 mm, 0.45 µm pore size, Transwell-clear (Costar Co., 
Cambridge, MA, USA) culture inserts. Cells were cultured in a 1:1 mixture of 
bronchial epithelial growth medium (BEGM): Dulbecco’s modified Eagle’s 
medium (DMEM) containing all supplements. The cultures were grown submerged 
for the first 9 days, during which time the culture medium was changed on Day 1 
and every other day thereafter. An air-liquid interface (ALI) was created on Day 9 
by removing the apical medium and restricting the culture feeding to the basal 
compartment. Following ALI creation the culture medium was changed daily. The 
cultured epithelial cells were treated with hypoxia on Day 16 of culture. 
 The human lung mucoepidermoid carcinoma cell line (NCI-H292) was 
purchased from the American Type Culture Collection (CRL-1848: Manassas, VA, 
USA) and cultured in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) supplemented 
with 10 % fetal bovine serum in the presence of penicillin-streptomycin at 37°C in 
a humidified chamber with 5% CO2. For serum deprivation, confluent cells were 
washed twice with phosphate-buffered saline and recultured in RPMI with 0.2% 
fetal bovine serum. Hypoxic condition was produced by Forma 1029 anaerobic 
chamber (Thermo Fisher Scientific, Waltham, MA, USA) containing a gaseous 
mixture of 95% N2 and 5% CO2. 
 
2. RNA isolation and reverse-transcriptase PCR 
 Total RNA was extracted from cells using TRizol® reagent (Invitrogen, 
Carlsbad, CA, USA) following the manufacturer’s instructions. Reverse 
transcription reactions were performed with 1 µg of total RNA, random hexamer 
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(Applied Biosystems, Foster City, CA, USA), AMV reverse transcriptase (Applied 
Biosystems), and RNase inhibitor (Applied Biosystems) in a final volume of 20 µl. 
The reverse transcription step was performed for 10min at room temperature and 
then 60 min at 42°C and 5 min at 95°C. RT-PCR performed with a MyCycler (Bio-
Rad, CA, USA) using the primer listed in Table 1. PCR parameters used involved 
24 cycles as follows: denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec, 
and polymerization at 72°C for 30 sec. The PCR products were run in a 2% agarose 
gel and visualized with ethidium bromide under a transilluminator. 
 
3. Real-time quantitative PCR 
 Real-time quantitative PCR analysis of MUC5AC gene expression was 
carried out with an Appylied Biosystems 7300 Fast Real-Time PCR system SYBR 
Green PCR Core Reagents (Applied Biosystems, Foster City, CA, USA). Reactions 
were performed in a total volume of 20 µl which included 10 µl of 2X SYBR Green 
PCR Master Mix, 300 nM of each primer, and 1 µl of previously reverse-
transcribed cDNA template. Primers are listed in Table 1.  The thermocycler 
parameters were 50°C for 2 min, and 95°C for 20 sec, followed by 40 cycles of 
95°C for 15 sec and 60°C for 30 sec. All reactions were performed in triplicate. The 
relative quantity of MUC5AC mRNA was obtained using the comparative cycle 
threshold method and was normalized using β2-microglobulin as an endogenous 
control.  
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Table 1. Primer used for PCR 
Gene name Primer sequences Product size 
MUC5AC 
(RT-PCR) 
Forward  
GTG GAA CCA CGA TGA CAG C 
Reverse 
TCA GCA CAT AGC TGC AGT CCG 
818 bp 
MUC5AC 
(Real-time PCR) 
Forward 
CAG CCA CGT CCC CTT CAA TA 
Reverse 
GAA CCG CAT TTG GGC ATC C 
66 bp 
β2-Micrglobulin 
(RT-PCR) 
Forward 
TCG CGC TAC TCT CTC TTT CTG G 
Reverse  
GCT TAC ATC TCT CGA TCC CAC TTA A 
334 bp 
 
β2-Micrglobulin 
(Real-time PCR) 
Forward 
CGC TCC GTG GCC TTA GC 
Reverse 
GAG TAC GCT GGA TAG CCT CCA 
67 bp 
HIF-1α 
(RT-PCR) 
Forward 
GCA GCC AGA TCT CGG CGA AG 
Reverse 
CTG TGT CCA GTT AGT TCA AAC TG 
319 bp 
 
4. Western blot analysis 
 After hypoxia treatment, the NHNE cells or NCI-H292 cells were lysed 
with cell extraction buffer (1 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1%Triton X-100, 10% 
glycerol 0.1 % SDS) (Invitrogen, Carlsbad, CA, USA) included 1 mM PMSF and 
10 % sodium deoxycholate. Equal amounts of whole cell lysates were resolved by 8% 
SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore, 
Bedford, MA, USA). Membranes were blocked with 5 % skim milk in Tris-
buffered saline (50 mM Tris-Cl pH 7.5, 150 mM NaCl) for 2 hr at room 
temperature. This blot was then incubated overnight with primary antibody (HIF-
1α) (1:1000) (BD Bioscience, San Jose, CA, USA) in TTBS (0.5 % Tween 20 in 
Tris-buffered saline). After washing with TTBS, the blot was further incubated for 
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1 hr at room temperature with anti-mouse secondary antibody (Cell Signaling, 
Danvers, MA, USA) in TTBS and then visualized by using the ECL system (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA). 
 
5. HIF-1α siRNA preparation and transfection  
 Specific siRNA against HIF-1α was used to suppress their respective 
expressions. HIF-1α siRNA oligonucleotides (Stealth
TM
 siRNA) were synthesized 
by Invitrogen (Invitrogen, Carlsbad, CA, USA). We screened HIF-1α mRNA 
(GenBank NM_001530) and selected potential siRNA sequences with high values 
of knock-down probability. The siRNA sequences were 5’-GUG GUU GGA UCU 
AAC ACU A-3’. Stealth RNAi negative control duplex (Medium GC, Invitrogen) 
was used as a siRNA negative control. siRNA transfection into NCI-H292 cells was 
carried out with Lipofectamine
TM
 2000 (Invitrogen) according to the manufacturer’s 
instructions. Ten pmole of each siRNA and 2 µl lipofectamine 
TM
 were mixed with 
RPMI without serum and antibiotics and then transfection was performed onto 6-
well NCI-H292 cells when the cells reached 30 - 50% confluence. This procedure 
did not affect cell viability. The same procedure was performed with control siRNA. 
 
6. Transient transfeciton of mammalian expression vector for HIF-1α 
 NCI-H292 cells were seeded into six-well plates and cultured for 24 hr 
before transfection. Cells were transfected with 1 µg of PCMV-HIF-1α containing 
the full length HIF-1α cDNA (HIF-1α overexpression plasmid), or PCMV-NN 
(negative control; empty vector) for 24 hr using FuGENE6 Transfection Reagent 
(Roche Applied Science, Mannheim, Germany) according to the manufacturer’s 
instructions. Cells were then treated with hypoxia and assayed by RT-PCR, real-
time PCR, or Western blot analysis. Dr. Koh EM at Sungkyunkwan University 
(Seoul, Korea) provided PCMV-HIF-1α overexpression plasmids.
24
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7. Transient transfection and luciferase analysis 
 NCI-H292 cells were transiently transfected with the plasmids for 
MUC5AC promoter luciferase assay with pGL3-basic, pGL3-MUC5AC promoter 
(-1376/+4), pGL3-mutated MUC5AC promoter (-1376/+4) using FuGENE 6 
transfection reagent (Roche Applied Science, Bagel, Switzerland) according to the 
manufacturer’s instructions in normoxia or hypoxia condition. After transfection of 
reporter, the cells were  incubated under the defined conditions for 6 hr and 
assayed for luciferase activity, using a luciferase assay system (Promega, Madison, 
Wisconsin, USA), according to the manufacturer’s instructions. Beta-galactosidase 
activity was also assayed to standardize the transfection efficiency of each sample. 
Mutation of the putative regulatory elements that start from -65 bp upstream of 
MUC5AC gene was generated by mutagenic PCR (5’-ACGTG-3’  5’-AAATG-
3’, -65/-61). 
 
 
8. Electrophoretic mobility shift assays (EMSAs)  
 The binding activity of HIF-1α and HRE on MUC5AC promoter was 
detected by EMSA. The single-stranded oligonucleotide sequence of 5’-ccc acc cac 
gtg aag cac g-3’, 3’-cgt gct tca cgt ggg tgg g-5’, which corresponds to the HIF-1α 
binding site, was end labeled with biotin (100 pmole, Bioneer, Daejeon, Korea). 
Cells were then resuspended in cell homogenization buffer containing 0.05% (v/v) 
Nodient P-40 and then homogenized. Next, nuclei were pelleted and resuspended in 
cell resuspension buffer (40 mM HEPES pH 7.9, 0.4 M KCl, 1 mM dithiothreitol, 
10% (v/v) glycerol, 0.1 mM phenlmethylsulfonylfluoride, 0.1 % (w/v) aprotinin and 
0.3 M NaCl). This nuclerar extract was then centrifuged at 14000 rpm for 10 min at 
4°C, and the supernatant was aliquoted and stored at -70°C. Five µg of nuclear 
extract were incubated at room temperature for 20 min with biotin-labeled–HRE 
oligonucleotide in Chemiluminescent Nucleic Acid Detection Kit (Thermo, 
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Rockford, IL, USA). Oligo-nuclear extract complex were separated by 
electrophoresis through 6% non-denaturing polyacrlyamide gels in 0.5X Tris 
borate-EDTA (TBE) buffer. The gel was transferred to Biodyne B pre-cut modified 
Nylon membranes (Thermo, Rockford, IL, USA). Blotting were used 
Chemiluminescent Nucleic Acid Detection Kit (Thermo, Rockford, IL USA). 
 
9. Immunohistochemical staining for MUC5AC and HIF-1α 
 Human mucosal samples were obtained from the maxillary sinus antral 
mucosa of the patients with sinusitis confirmed by CT and normal human sample 
were obtained from normal-appearing ethmoid mucosa of that subjects. The normal 
sample and sinusitis samples were fixed with 10% formaldehyde solution for 24 hr 
and then dehydrated and embedded in paraffin. Paraffin blocks were sectioned into 
4 µm-thick slices and fixed. After deparaffinization and rehydration, slides were 
incubated in antigen retrieval solution (Tris-EDTA, pH 9.0) for 20 min at 90-95°C. 
To block endogenous peroxidase, slides were treated with 0.3 % H202 for 15 min at 
room temperature. Slides were blocked with 10% normal serum with 1% BSA in 
TBS for 2 hr at room temperature, and then incubated overnight at 4°C with a 
monoclonal mouse antibody against human MUC5AC (1:100 Jackson Immune 
Research, Sacramento, CA, USA) and HIF-1α (BD Bioscience, San Jose, CA, 
USA). The slides were then incubated with HRP-conjugated goat anti-mouse IgG 
(1:200; Jackson Immune Research) in antibody diluent solution (DAKO, Glostrup, 
Denmark) at room temperature and counterstained with hematoxylin (Merck, 
Darmstadt, Germany). 
 
 12 
10. Statistical analysis 
 Data are presented as means + SD of at least three independent 
experiments. Where appropriate, statistical differences were assessed by Wilcoxon 
Mann–Whitney tests. A p-value less than 0.05 was considered statistically 
significant. 
 III. RESULTS 
 
1. Messenger RNA expression of MUC5AC
NHNE cells 
 To determine whether hypoxic stimulation induces 
MUC5AC gene in NHNE cells, mRNA expression of 
analysed by real-time PCR after incubating the 
with 95% N2, 5% CO2 in time-dependant manner
were measured with increasing time at 0, 
Compared with non-treated cells, the mRNA 
a function of time in the cells under hypoxic treatment. These results indicate that 
MUC5AC expression in NHNE cells is induced by hypoxia (
Figure 1. mRNA expression of MUC5AC 
NHNE cells. NHNE cells were exposed to 95% N
for 0 - 12 hr. Total RNA of the NHNE cells was isolated and the expression level of 
mRNA of MUC5AC was analyzed by real
mRNA was increased under the hypoxic condition 
hypoxic treatment having its peak in 4 hr.
13 
 according to hypoxic stimulation in 
the expression of 
MUC5AC in NHNE cell was 
NHNE cells in the hypoxic chamber 
.  The mRNA levels of MUC5AC 
1, 2, 4, 6 and 12 hr after hypoxic treatment. 
levels of MUC5AC were increased as 
Fig. 1). 
 
according to hypoxic stimulation in 
2, 5% CO2 in the hypoxic chamber 
-time PCR. The expression of MUC5AC 
as a function of time under 
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2. Loss-of-function study with siRNA for HIF-1α in NCI-H292 cells 
 To determine whether HIF-1α is involved in the regulation of MUC5AC 
by hypoxia, siRNA for HIF-1α or control siRNA was transiently transfected into 
the human mucoepidermoid carcinomal cell lines (NCI-H292 cells). And then, 
these cells were treated with hypoxia for 12 hr. Initially, western blot analysis was 
carried out to confirm the expression of HIF-1α. We could confirm the effect of 
siRNA for HIF-1α with the reduction of over-expressed HIF-1α protein by siRNA 
for HIF-1α compared to those of control siRNA (Fig. 2A). By the transfection of 
siRNA for HIF-1α, hypoxia-induced over-expression of MUC5AC mRNA was 
decreased with RT-PCR (Fig. 2B) and also with real-time PCR (Fig. 2C).  
      A                                  
           C  
 
 
 
 
 
 
Figure 2. Loss-of-function study with 
H292 cells transient-trnasfected with siRNA for HIF
incubated in hypoxic chamber with 
expression of HIF-1α protein by hypoxia was decreased by transfection of siRNA 
for HIF-1α compared to those of control siRNA
HIF-1α, induced expression of MUC5AC mRNA was 
accordingly using RT-PCR analysis. C: This finding was also confirmed with real
time PCR analysis. 
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B  
 
siRNA for HIF-1α in NCI-H292 cells. NCI-
-1α or control siRNA were 
95% N2, 5% CO2 for 12 hr. A: Induced 
. B: By transfection of siRNA for 
remarkably decreased 
-
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3. Gain-of-function study with mammalian expression vector for HIF-1α in 
NCI-H292 cells 
 To examine the functional role of HIF-1α in MUC5AC gene expression, 
we used mammalian expression vector for HIF-1α in NCI-H292 cells. We 
transiently transfected the cells with vector containing HIF-1α (pCMV-HIF-1α: 
generous gift from Dr. Koh EM, Sungkyunkwan University, Seoul, Korea). Initially, 
western blot analysis was carried out to confirm the expression of HIF-1α. The 
expression was increased in the cells tranfected with HIF-1α expression plasmids 
compared to the cells with empty vectors even in normoxic condition (Fig. 3A). 
Messenger RNA of MUC5AC was measured by RT-PCR which showed that 
transfection of plasmids encoding HIF-1α increased the expression of MUC5AC 
mRNA in the NCI-H292 cells (Fig. 3B). This was also confirmed in real-time PCR 
experiments (Fig. 3C) 
   A                              
                 C 
 
 
 
 
 
Figure 3. Gain-of-function study with mammalian expression vector
NCI-H292 cells. A: pCMV vector encoding HIF
1α were transiently transfected into NCI
increased in the cells transfected with pCMV
with empty vectors even in the normoxic condition. 
MUC5AC. The increase of MUC5AC mRNA was noted in the cells with pCMV 
vectors encoding HIF-1α compared to the cells with empty vectors. 
also confirmed in real-time PCR experiments.
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    B 
 
 for HIF-1α in 
-1α or pCMV vector without HIF-
-292 cells. The expression of HIF-1α was 
-HIF-1α vector compared to the cells 
B: mRNA expression of 
C: This was 
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4. Luciferase assay of MUC5AC promotor in hypoxia 
 To figure out whether putative HRE of MUC5AC promoter plays a 
important role in hypoxia-induced MUC5AC expression, luciferase assay with 
mutagenesis of putative HRE was carried out. The putative HRE is located 
61~65bp upstream of the MUC5AC gene, of which sequence is 5’-ACGTG-3’. By 
mutagenic PCR, putative HRE sequence was mutated to 5’-AAATG-3’. These 
wild-type or HRE-mutated MUC5AC promoters were inserted into pGL3 
plasmids, which have the luciferase reporter gene. NCI-H292 cells were 
transfected with pGL3 vectors containing wild-type MUC5AC promoter, pGL3 
vectors with HRE-mutated MUC5AC promoter, and pGL3-basic vectors, 
respectively. After treatment of hypoxia with 95% N2, 5% CO2 for 6 h, the relative 
luciferase activity in the cells with pGL3-wild-type MUC5AC promoter was 
increased by 5.11-fold compared to the HRE-mutated group and by 6.44-fold 
compared to the pGL3-basic vector group. In normoxia, the luciferase activity in 
the cells with plasmids encoding wild-type MUC5AC promoter was increased 
compared to the groups with either HRE-mutated promoter or pGL3-basic vector. 
Compared with the normoxic condition, the luciferase activity was increased by 
1.8-fold in the cells with wild-type MUC5AC promoter in the hypoxic condition. 
Hypoxic stimulation did not increase the activity of luciferase reporter when the 
MUC5AC promoter HRE was mutated (Fig. 4). This result implicates that 
putative HRE located on MUC5AC promoter plays a important role in hypoxia-
induced MUC5AC expression. 
 
 
 
 Figure 4. Luciferase assay of MUC5AC promoter
transfected with pGL3-basic vectors, pGL3 vectors encoding wild
promoter, or pGL3 vectors encoding HRE
were incubated in the hypoxic chamber with 95% N
luciferase activity was increased by 1.8
promoter in the hypoxic condition compared with the normoxic condition. H
stimulation did not increase the activity of luciferase reporter when the MUC5AC 
promoter HRE was mutated.  
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. NCI-H292 cells were 
-type MUC5AC 
-mutated MUC5AC promoter. After cells 
2, 5% CO2 for 6 hr, the 
-fold in the cells with wild-type MUC5AC 
ypoxic 
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5. HIF-1α binding to the MUC5AC promoter in response to hypoxia 
 To analyze the DNA binding activity of hypoxia-induced-HIF-1α, we 
performed an EMSA assay using the nuclear extracts of hypoxia-treated NHNE 
cells (Fig. 5). The activities of HIF-1α specific HRE-oligonucleotides increased 
remarkably in response to hypoxia. These results indicate that induced HIF-1α 
binds to a HRE in the MUC5AC promoter.  
 
Figure 5. HIF-1α binding to the HRE in response to hypoxia. Nuclear protein 
extract from hypoxia-treated NHNE cells was subjected to an electromobility shift 
assay. The activities of HIF-1α specific HRE-oligonucleotides increased 
remarkably in response to hypoxia.  
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6. HIF-1α protein expression in normal vs. sinusitis mucosa 
 Based on our result, we wanted to examine the HIF-1α expression in 
human samples. We conducted Western blot analysis with mucosal sample of 
sinusitis patients vs. normal ethmoid mucosal samples of same subject. The results 
showed that HIF-1α protein was obviously over-expressed in the sinusitis samples 
compared to normal samples (Fig. 6A). In densitometric comparison, expression of 
HIF-1α was 4.4-fold higher in sinusitis samples compared to normal samples (Fig. 
6B). We also confirmed induced expression of HIF-1α protein in sinusitis samples 
with immunohistochemical staining (Fig. 6C). 
    A 
 B                          C 
      
 
Figure 6. HIF-1α protein expression in normal vs. sinusitis mucosa
protein was obviously over-expressed in the sinusitis samples compared to normal 
samples. B: In densitometric comparison, expression of HIF
in sinusitis samples compared to normal
with immunohistochemical staining for HIF
N S  N S 
α-tubulin 
HIF-1α 
Patient #1 Patient #2 
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. A: HIF-1α 
-1α was 4.4-fold higher 
 samples. C: This result was also confirmed 
-1α in sinusitis samples. 
N S  N S  
Patient #3 Patient #4 
 7. MUC5AC expression in normal vs. 
 We also investigated the expression of 
1α, in normal versus sinusitis mucosa
MUC5AC was highly expressed throughout the epithelium of sinusitis
hypoxia is supposed to be present by occlusion of sinusus ositum
      
Figure 7. MUC5AC expression in normal vs. sinusitis mucosa
upregulated MUC5AC expression in sinusitis mucosa, where the hypoxia is 
supposed to be present by occlusion of sinusus ositum.
23 
sinusitis mucosa 
MUC5AC, target protein for HIF-
 by immnohistochemical staining (Fig. 7). 
, where the 
.  
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IV. DISCUSSION 
 This study was performed based on the presumption that the hypoxic 
condition within the sinuses can directly induce the hypersecretin of mucin which is 
one of the major pathophysiologic mechanisms of sinusitis. Although hypoxia is 
known as a potent stimulant for inflammation
8
 and tissue remodeling
25
 that can 
contribute to sinus diseases, no studies have been performed to investigate the effect 
of hypoxia on mucin secretion in airway epithelial system. Only MUC3 gene in 
intestinal epithelium is known to be regulated by hypoxic stimulation.
26
  
 This study demonstrated that the MUC5AC gene is induced by hypoxia in 
normal human nasal epithelial cells (Fig. 1). The transcriptional initiation of 
MUC5AC occurred after the cells were exposed to hypoxic conditions. One 
possible mechanism by which hypoxia can regulate MUC5AC gene expression is 
through the transcription factor HIF-1. HIF-1 is heterodimeric proteins composed of 
an oxygen regulated α subunit and an oxygen independent β subunit.
27
 The α 
subunits are continuously transcribed and translated. Under normoxic conditions, 
two prolines in the α subunit are hydroxylated, which enables the protein to be 
ubiquinated by the von Hippel-Lindau tumor suppressor and degraded in the 26S 
proteosome.
28
 When oxygen levels decrease, the α and β subunits heterodimerize 
and bind to specific elements (hypoxia-response element) in promoters of various 
genes to induce transcription. In this study, although the mRNA expression of HIF-
1α was not influenced by hypoxic stimulations (not shown), the protein level of 
HIF-1α was increased with time under hypoxic conditions (not shown), which 
suggests post-translational regulation of HIF-1α protein.  
 We found that the MUC5AC promoter region contains a putative HRE. 
The HRE of the MUC5AC promoter exhibits core sequence ACGTG that are 
similar to the sequences found in the promoters of transferrin or lactate 
dehydrogenase. To evaluate the importance of HIF-1α for induction of MUC5AC in 
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hypoxic condition, we conducted loss-of-function test using siRNA for HIF-1α in 
hypoxic condition. By knock-down of HIF-1α gene expression, MUC5AC mRNA 
expression was reduced accordingly (Fig. 2). This result indicates that transcription 
factor HIF-1a is important factor for induction of MUC5AC by hypoxia. 
 To evaluate the role of HIF-1α, we also conducted the gain-of-function test. 
HIF-1α expression vectors were transfected in human lung mucoepidermoid 
carcinoma cell lines. The MUC5AC promoter activity was enhanced by increased 
expression of HIF-1α even in the normoxic condition. However, compared to the 
increased amount of HIF-1α protein (Fig. 3A), the increased MUC5AC mRNA 
levels in the cells with overexpression of HIF-1α did not appear to be sufficient (Fig. 
3B, 3C). It may be suggested that additional overexpression of HIF-1β could 
contribute to higher activity of MUC5AC promoter as observed in other studies in 
which co-transfection of HIF-1α and HIF-1β resulted in higher activity of 
transferrin receptor promoter than HIF-1α alone.
29
 These results suggest that the 
MUC5AC gene contains an enhancer regulated by HIF-1. Moreover, our studies 
demonstrated that the wild-type but not HRE-mutated MUC5AC promoter 
conferred inducibility to the luciferase reporter gene under the hypoxic condition in 
NCI-H292 cells (Fig. 4). However, the difference of relative activity between the 
cells incubated in the hypoxic and normoxic conditions was not very significant, 
meaning that there may be another mechanism involved in activating the MUC5AC 
gene mediated by the putative HRE. 
 Because putative HRE-mutated MUC5AC promoter attenuated the 
reporter activity, putative HRE in the MUC5AC promoter can be a strong candidate 
for a functional HRE. To confirm whether HIF-1α can bind to the putative HRE in 
the MUC5AC promoter, EMSA was performed. Our study reveals that hypoxia can 
contribute to the sinus disease by directly regulating MUC5AC secretion via the 
activation of HIF-1α.  
 26 
 MUC5AC is the one of the major secreted mucin in sinusitis. Considering 
that a marked increase of MUC5AC and MUC5B secretion was reported in sinus 
diseases and the mean level of MUC5AC expression was higher compared to 
MUC5B in sinus mucus secretion,
30
 the role of hypoxic stress in the 
pathophysiology of sinusitis could be more accentuated. Therefore, in the 
management of upper airway diseases like sinusitis, the mechanical or 
pharmacological restoration of ventilation would be crucial. 
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Ⅴ. CONCLUSION 
 Our study revealed that the expression and secretion of MUC5AC, which 
is the major component of mucus in sinusitis, can be increased with hypoxic 
stimulation in NHNE cells. HIF-1α is the well-known transcription factor which 
activates several genes responding to hypoxic stimulation. The alteration of the 
activity of HIF-1α by overexpression or siRNA of HIF-1α affected the expression 
of MUC5AC. Mutation of the putative HRE in the MUC5AC promoter attenuated 
the reporter activity in promoter luciferase assay. Hypoxia-induced MUC5AC over-
expression was mediated by binding of HIF-1α to HRE in the promoter of 
MUC5AC.  
 In conclusion, hypoxia upregulates mucin gene expression and secretion 
by signaling using HIF-1α in the airway epithelia and hypoxia might be a 
pathophysiologic mechanism of hypersecretion in airway diseases such as sinusitis. 
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ABSTRACT (IN KOREAN) 
저산소에 의한 부비동염의 과분비 기전규명 
 
<지도교수 윤주헌> 
 
연세대학교 대학원 의과학과 
 
김 윤 주 
 
 과도한 점액 생성 및 과분비는 여러 상기도 질환의 특징이다. 
부비동염에서 중요 점액인 MUC5AC와 MUC5B의 발현이 증가되어 
있다고 알려져 있다. 하지만 부비동염에서 어떠한 기전에 의해 점액의 
과분비가 유도되는 지는 아직 잘 알려지지 않았다. 부비동 개구부의 
폐쇄에 의한 저산소증은 부비동염의 가장 중요한 병인으로 알려져 있다. 
하지만 부비동염에서 저산소증에 의해 유도되는 과분비 기전은 아직 잘 
알려지지 않았다.  
 이 연구의 목적은 저산소에 의해 점액의 과분비가 일어나는지, 
그렇다면 저산소에 의해 유도되는 점액 과분비의 기전은 어떠한지를 
알아보고자 하였다. 
 본 연구자는 배양된 정상사람 코점막상피세포에서 시간에 따른 
저산소 처치에 의해 MUC5AC의 유전자 발현이 증가함을 보였다. 또한 
이러한 증가가 저산소의 중요 전사인자인 HIF-1α의 siRNA 처치에 의해 
감소함을 보였고, 과발현 벡터를 transfection함으로써 정상 
산소조건에서도 MUC5AC 유전자의 과발현을 유도할 수 있었다. 
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Luciferase 실험을 통해 저산소 환경에서 MUC5AC의 reporter 활성이 
증가함을 관찰할 수 있었는데, 이는 MUC5AC의 promoter에 존재하는 
HRE의 mutation을 통해 감소됨을 확인할 수 있었다. 연구자는 과발현된 
HIF-1α 전사인자와 MUC5AC promoter에 존재하는 HRE와의 결합을 
EMSA 방법을 통하여 확인할 수 있었다. 사람 부비동염 샘플에서 HIF-1α 
단백과 MUC5AC 단백의 과발현을 면역화학염색을 통해 확인할 수 
있었다. 
 이 연구를 통해 저산소가 HIF-1α와 MUC5AC의 promoter에 
존재하는 HRE와의 결합을 통해 MUC5AC의 발현을 증가시킴을 알 수 
있었다. 결론적으로 저산소는 HIF-1α 전사조절에 의해 점액의 발현 및 
분비를 조절함을 알 수 있었고, 저산소가 부비동염과 같은 기도질환에서 
과분비를 일으키는 중요 병인으로써의 역할을 함을 알 수 있었다. 
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